-
EP2481753
European procedure
Extract from the Register of European Patents
EP About this file: EP2481753
| EP2481753 - Anti-IL-17 Antibodies [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.02.2019 Database last updated on 05.05.2025 | |
| Former | The patent has been granted Status updated on 16.03.2018 | ||
| Former | Grant of patent is intended Status updated on 09.11.2017 | ||
| Former | Examination is in progress Status updated on 08.03.2017 | Most recent event Tooltip | 22.02.2019 | No opposition filed within time limit | published on 27.03.2019 [2019/13] | Applicant(s) | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2012/31] | Inventor(s) | 01 /
Allan, Barrett Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 02 /
Chow, Chi-kin Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 03 /
Huang, Lihua Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 04 /
Liu, Ling Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 05 /
Lu, Jirong Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 06 /
Ng, Kingman 10745 Putnam Place Carmel, Indiana 46032 / US | 07 /
Tetreault, Jonathan Wendell Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | 08 /
Werner, Andrew Gordon Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2012/31] | Representative(s) | Kent, Lindsey Ruth Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [N/P] |
| Former [2012/31] | Kent, Lindsey Ruth Eli Lilly and Company Limited Lilly Research Center European Patent Operations Sunninghill Road, Earl Wood Manor, Windlesham Surrey GU20 6PH / GB | Application number, filing date | 11192240.7 | 05.12.2006 | [2012/31] | Priority number, date | US20050749953P | 13.12.2005 Original published format: US 749953 P | US20060801948P | 19.05.2006 Original published format: US 801948 P | [2012/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2481753 | Date: | 01.08.2012 | Language: | EN | [2012/31] | Type: | B1 Patent specification | No.: | EP2481753 | Date: | 18.04.2018 | Language: | EN | [2018/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.06.2012 | Classification | IPC: | C07K16/24, A61K39/395 | [2012/31] | CPC: |
C07K16/244 (EP,NO,US);
C07K16/24 (KR);
A61K39/395 (KR);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07K16/00 (KR);
A61K2039/505 (EP,US);
C07K2317/34 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2018/16] |
| Former [2012/31] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 01.02.2013 | BA | 01.02.2013 | HR | 01.02.2013 | MK | 01.02.2013 | RS | 01.02.2013 | Title | German: | Antikörper gegen IL-17 | [2012/31] | English: | Anti-IL-17 Antibodies | [2012/31] | French: | Anticorps anti-IL-17 | [2012/31] | Examination procedure | 30.01.2013 | Amendment by applicant (claims and/or description) | 01.02.2013 | Examination requested [2013/11] | 14.04.2014 | Despatch of a communication from the examining division (Time limit: M06) | 21.10.2014 | Reply to a communication from the examining division | 09.10.2015 | Despatch of a communication from the examining division (Time limit: M06) | 01.04.2016 | Reply to a communication from the examining division | 27.02.2017 | Despatch of a communication from the examining division (Time limit: M04) | 04.07.2017 | Reply to a communication from the examining division | 10.11.2017 | Communication of intention to grant the patent | 08.03.2018 | Fee for grant paid | 08.03.2018 | Fee for publishing/printing paid | 08.03.2018 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06846464.3 / EP1963368 | Divisional application(s) | EP18160779.7 / EP3366702 | EP20190492.7 / EP3808769 | Opposition(s) | 21.01.2019 | No opposition filed within time limit [2019/13] | Fees paid | Renewal fee | 10.04.2012 | Renewal fee patent year 03 | 10.04.2012 | Renewal fee patent year 04 | 10.04.2012 | Renewal fee patent year 05 | 10.04.2012 | Renewal fee patent year 06 | 02.01.2013 | Renewal fee patent year 07 | 02.01.2014 | Renewal fee patent year 08 | 05.01.2015 | Renewal fee patent year 09 | 04.01.2016 | Renewal fee patent year 10 | 02.01.2017 | Renewal fee patent year 11 | 02.01.2018 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]WO2004106377 (CELLTECH R&D LTD [GB], et al) [I] 1-11 * page 30 * [Y] 12-15; | [AP]WO2006013107 (NOVARTIS AG [CH], et al) [AP] 1-15 * page 38 * * page 41 *; | [AP]WO2006054059 (UCB CELLTECH [GB], et al) [AP] 1-15 * page 32 - page 33 * * page 26 *; | [Y] - HOFSTETTER ET AL, "Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis", CELLULAR IMMUNOLOGY, ACADEMIC PRESS, SAN DIEGO, CA, US, (200510), vol. 237, no. 2, ISSN 0008-8749, pages 123 - 130, XP005253007 [Y] 12-15 * abstract * DOI: http://dx.doi.org/10.1016/j.cellimm.2005.11.002 | [A] - GIAVEDONI L D, "Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (200506), vol. 301, no. 1-2, ISSN 0022-1759, pages 89 - 101, XP004976653 [A] 1 * table 1 * DOI: http://dx.doi.org/10.1016/j.jim.2005.03.015 | [A] - MOSELEY T A ET AL, "Interleukin-17 family and IL-17 receptors", CYTOKINE AND GROWTH FACTOR REVIEWS, OXFORD, GB, (200304), vol. 14, no. 2, ISSN 1359-6101, pages 155 - 174, XP002321611 [A] 1-15 * table 1 * DOI: http://dx.doi.org/10.1016/S1359-6101(03)00002-9 | [A] - LUBBERTS E, "THE ROLE OF IL-17 AND FAMILY MEMBERS IN THE PATHOGENESIS OF ARTHRITIS", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (200305), vol. 4, no. 5, ISSN 1472-4472, pages 572 - 577, XP009056201 [A] 1-15 * the whole document * | by applicant | WO8601533 | US4816567 | US4816397 | EP0125023 | US5225539 | EP0120694 | EP0194276 | WO9404679 | EP0239400 | US5545806 | US5545807 | US5569825 | US5585089 | US5589369 | US5591669 | US5612205 | US5625126 | US5625825 | US5633425 | US5661016 | US5693761 | US5698762 | US5721367 | EP0843961 | US5770429 | US5789650 | US5789215 | US5807715 | US5814318 | US6284471 | WO2005005604 | - YAO, Z. ET AL., IMMUNITY, (1995), vol. 3, page 811 | - KOLLS; LINDEN, IMMUNITY, (2004), vol. 21, pages 467 - 476 | - FOSSIEZ ET AL., INT. REV. IMMUNOL., (1998), vol. 16, page 541 | - WITKOWSKI ET AL., CELL. MOL. LIFE SCI., (2004), vol. 61, pages 567 - 579 | - LUBBERTS ET AL., ARTHRITIS & RHEUMATISM, (2004), vol. 50, pages 650 - 659 | - PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 269 - 315 | - KABAT ET AL., ANN. AT ACAD. SCI., (1971), vol. 190, pages 382 - 93 | - KOHLER ET AL., NATURE, (1975), vol. 256, page 495 | - JAKOBOVITS ET AL., PROC. NATL. ACAD SCI. USA, (1993), vol. 90, pages 2551 - 2555 | - JAKOBOVITS ET AL., NATURE, (1993), vol. 362, pages 255 - 258 | - PLUCKTHUN, The Pharmacology ofallonoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 269 - 315 | - MATTHEWS DJ; WELLS JA., SCIENCE., (1993), vol. 260, pages 1113 - 7 | - HANES ET AL., PROC. NATL. ACAD SCI. (USA, (1998), vol. 95, pages 14130 - 5 | - SAMUELSON P. ET AL., JOURNAL OF BIOTECHNOLOGY., (2002), vol. 96, pages 129 - 54 | - KIEKE M.C. ET AL., PROTEIN ENGINEERING, (1997), vol. 10, pages 1303 - 10 | - LITTLE M. ET AL., IMMUNOLOGY TODAY, (2000), vol. 21, pages 364 - 70 | - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 6 | - HUSTON ET AL., PROC. NATL. ACAD SCI. USA, (1988), vol. 85, pages 5879 - 83 | - MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 4 | - URLAUB; CHASIN, PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 20 | - KAUFMAN; SHARP, J MOL. BIOL., (1982), vol. 159, pages 601 - 21 | - TAYLOR ET AL., NUCLEIC ACIDS RES., (1992), vol. 20, pages 6287 - 95 | - JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525 | - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329 | - PRESTA, CURR. OP. STRUCT. BIOL., (1992), vol. 2, pages 593 - 596 | - KETTLEBOROUGH, C.A. ET AL., PROTEIN ENGINEERING, (1991), vol. 4, pages 773 - 783 | - QUEEN ET AL., PROC. NATL. ACAD SCI. USA, (1991), vol. 88, page 2869 | - LEVITT, M., V., MOL. BIOL., (1983), vol. 168, pages 595 - 620 | - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327 | - VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536 | - HOOGENBOOM; WINTER, J MOL. BIOL., (1991), vol. 227, page 381 | - MARKS ET AL., J MOL. BIOL., (1991), vol. 222, page 581 | - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, (1985), page 77 | - BOERNER ET AL., J IMMUNOL., (1991), vol. 147, pages 86 - 95 | - MARKS ET AL., BIOTECHNOLOGY, (1992), vol. 10, pages 779 - 783 | - LONBERG ET AL., NATURE, (1994), vol. 368, pages 856 - 859 | - MORRISON, NATURE, (1994), vol. 368, pages 812 - 13 | - FISHWILD ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 845 - 51 | - NEUBERGER, NATURE BIOTECHNOLOGY, (1996), vol. 14, page 826 | - LONBERG; HUSZAR, INTERN. REV. IMMUNOL., (1995), vol. 13, pages 65 - 93 | - JOBKOBOVITS ET AL., PROC. NATL. ACAD SCI. USA, (1993), vol. 90, page 2551 | - BRUGGEMANN ET AL., PROC. NAT'L. ACAD SCI. USA, (1989), vol. 86, pages 6709 - 6713 | - MENDEZ ET AL., NATURE GENETICS, (1997), vol. 15, pages 146 - 156 | - GREEN; JAKOBOVITS, J EXP. MED., (1998), vol. 188, pages 483 - 495 | - HUNTER ET AL., NATURE, (1962), vol. 144, page 945 | - DAVID ET AL., BIOCHEMISTRY, (1974), vol. 13, page 1014 | - PAIN ET AL., J IMMUNOL. METH., (1981), vol. 40, page 219 | - NYGREN, J., HISTOCHEM. AND CYTOCHEM., (1982), vol. 30, page 407 | - ANN. RHEUM. DIS., (2000), vol. 59, pages 529 - 32 | - J. IMMUNOL., (2001), vol. 167, pages 1004 - 1013 | - J. IMMUNOL., (2003), vol. 171, pages 6173 - 6177 | - MULTIPLE SCLEROSIS, (1999), vol. 5, pages 101 - 104 | - J IMM., (1995), vol. 155, pages 5483 - 5486 | - CYTOKINE, (1997), vol. 9, pages 794 - 800 | - HOOFNAGLE, A. ET AL., METHODS MOL. BIOL., (2004), vol. 250, pages 283 - 298 | - HOOFNAGLE, A. ET AL., ANN. REV. BIOPHYS. BIOMOL. STRUCT., (2003), vol. 32, pages 1 - 25 | - BAERGA-ORTIZ, A. ET AL., PROTEIN SCI., (2002), vol. 11, pages 1300 - 8 | - E. BLASI ET AL., J IMMUNOLOGY, (1990), vol. 27, pages 229 - 237 | - FASEB JOURNAL., (2004), vol. 18, pages 1550 - 1552 | - LOCK ET AL., NAT. MED., (2002), vol. 8, pages 500 - 508 | - MATUSEVICIUS ET AL., MULTIPLE SCLEROSIS., (1999), vol. 5, pages 1 - 1,104 | - NAKAE ET AL., J IMMUN., vol. 171, pages 6173 - 6177 | - I EXP. MED., (2001), vol. 194, pages 873 - 881 | - TRENTHAM, D ET AL., J EXP. MED., (1977), vol. 146, pages 857 - 858 | - BLIVEN, M. ET AL., ARTHRITIS & RHEUMATISM, (1986), vol. 29, pages 1131 - 1138 |